Dr. Emanuel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-360-0000Fax+1 214-739-8562
Education & Training
- University of Miami Hospital and ClinicsFellowship, Glaucoma, 2013 - 2014
- Emory University School of MedicineResidency, Ophthalmology, 2010 - 2013
- Arrowhead Regional Medical CenterInternship, Transitional Year, 2009 - 2010
- Vanderbilt University School of MedicineClass of 2009
Certifications & Licensure
- TX State Medical License 2014 - 2025
- FL State Medical License 2013 - 2015
- GA State Medical License Active through 2013
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 20 citationsThe Canonical Wnt Signaling Pathway Inhibits the Glucocorticoid Receptor Signaling Pathway in the Trabecular MeshworkChenna Kesavulu Sugali, Naga Pradeep Rayana, Jiannong Dai, Michael Peng, Sherri L Harris
The American Journal of Pathology. 2021-03-08 - 7 citations24 Month Outcome of Gonioscopy Assisted Transluminal Trabeculotomy (GATT) in Eyes with Prior Corneal Transplant Surgery.Oluwatosin U. Smith, Michelle R. Butler, Davinder S. Grover, Helen L. Kornmann, Matthew E. Emanuel
Journal of Glaucoma. 2021-10-11 - 118 citationsMicropulse Cyclophotocoagulation: Initial Results in Refractory Glaucoma.Matthew E. Emanuel, Davinder S. Grover, Ronald L. Fellman, David G. Godfrey, Oluwatosin U Smith
Journal of Glaucoma. 2017-08-01
Authored Content
- Long-Term Safety of YAG Laser Iridotomy on Corneal Endothelium in Angle-Closure SuspectsNovember 2021
- Systemic Beta-Blockers Have Negligible Effect on IOP ReductionJanuary 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: